Department of Medicinal Chemistry
University of Illinois, United States
Kelvin joined Bristol Myers Squibb Company in 2012 as a Scientist. He prepares forced degradation studies for investigating the Critical Quality Attribute for BLA filings and performs extended biophysical characterization of new drug candidates for IND filings.
Analytical method development and validation; Immunological, biochemical and cell-based assay development; Protein formulation and stability; Biophysical and biochemical characterization and analysis; Protein mass spectrometry and proteomics